| 000 | 01771 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516152621.0 | ||
| 264 | 0 | _c20131209 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1553-7374 | ||
| 024 | 7 |
_a10.1371/journal.ppat.1003343 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Vries, Erhard | |
| 245 | 0 | 0 |
_aProlonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets. _h[electronic resource] |
| 260 |
_bPLoS pathogens _c2013 |
||
| 300 |
_ae1003343 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFerrets |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aInfluenza A Virus, H1N1 Subtype _ximmunology |
| 650 | 0 | 4 |
_aInfluenza, Human _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOseltamivir _xadministration & dosage |
| 650 | 0 | 4 | _aPandemics |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aVirus Shedding _xdrug effects |
| 700 | 1 | _aStittelaar, Koert J | |
| 700 | 1 | _avan Amerongen, Geert | |
| 700 | 1 | _aVeldhuis Kroeze, Edwin J B | |
| 700 | 1 | _ade Waal, Leon | |
| 700 | 1 | _aFraaij, Pieter L A | |
| 700 | 1 | _aMeesters, Roland J | |
| 700 | 1 | _aLuider, Theo M | |
| 700 | 1 | _avan der Nagel, Bart | |
| 700 | 1 | _aKoch, Birgit | |
| 700 | 1 | _aVulto, Arnold G | |
| 700 | 1 | _aSchutten, Martin | |
| 700 | 1 | _aOsterhaus, Albert D M E | |
| 773 | 0 |
_tPLoS pathogens _gvol. 9 _gno. 5 _gp. e1003343 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.ppat.1003343 _zAvailable from publisher's website |
| 999 |
_c22789605 _d22789605 |
||